EssilorLuxottica S. A. - End Period Cash Flow
EssilorLuxottica S. A.'s Fiscal Year is From January To December - All Figures are in EUR, Billions.
The item "End-Period-Cash-Flow" stands at 5.04 Billion Euros for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 09/30/2022.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 30.80 percent compared to the value the year prior.
The 1 year change in percent is 30.80.
The 3 year change in percent is -47.18.
The 5 year change in percent is -65.24.
The 10 year change in percent is 264.14.
The Serie's change in percent from it's minimum value, on 09/30/2011, to it's latest available value, on 06/30/2025, is +1,303.83%.
The Serie's change in percent from it's maximum value, on 09/30/2021, to it's latest available value, on 06/30/2025, is -78.39%.
End Period Cash Flow for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Abbott Laboratories - End Period Cash Flow | 217,696,616,448.00 |
 | Intuitive Surgical Inc - End Period Cash Flow | 206,245,888,000.00 |
 | Danaher Corporation - End Period Cash Flow | 162,006,663,168.00 |
 | Boston Scientific Corp - End Period Cash Flow | 144,567,730,176.00 |
 | Stryker Corporation - End Period Cash Flow | 139,209,850,880.00 |